VIRGINIA RETIREMENT SYSTEMS ET AL - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$884,940
-54.2%
43,000
+4.6%
0.01%
-52.6%
Q2 2023$1,932,522
+40.8%
41,100
+25.7%
0.02%
+35.7%
Q1 2023$1,372,092
+16.8%
32,700
+6.2%
0.01%
+16.7%
Q4 2022$1,174,712
+4.5%
30,800
+7.3%
0.01%
-7.7%
Q3 2022$1,123,892
+4.5%
28,700
-11.7%
0.01%
+30.0%
Q1 2022$1,076,000
-29.5%
32,500
-9.5%
0.01%0.0%
Q4 2021$1,527,000
-13.8%
35,900
-10.2%
0.01%
-44.4%
Q3 2021$1,772,000
-19.6%
40,000
+3.1%
0.02%
-18.2%
Q2 2021$2,204,000
+110.3%
38,800
+177.1%
0.02%
+120.0%
Q1 2021$1,048,000
+95.5%
14,000
+125.8%
0.01%
+66.7%
Q4 2020$536,000
+3.1%
6,200
-27.1%
0.01%0.0%
Q3 2020$520,000
+19.0%
8,500
-19.0%
0.01%
+20.0%
Q2 2020$437,000
+97.7%
10,500
+36.4%
0.01%
+66.7%
Q1 2020$221,000
-58.6%
7,700
+4.1%
0.00%
-50.0%
Q4 2019$534,000
-32.1%
7,400
+32.1%
0.01%
-33.3%
Q3 2019$786,000
+7.4%
5,600
+40.0%
0.01%
+12.5%
Q2 2019$732,000
+4.6%
4,000
-9.1%
0.01%0.0%
Q1 2019$700,000
+170.3%
4,400
+63.0%
0.01%
+100.0%
Q4 2018$259,0002,7000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders